Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2015

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #2411

    Ja såfremt at data lever op til det vi håber - Jan har dog før sat forventningerne for højt, så vi skal lige have det vi ønsker først.

    1 Reply Last reply
    0
    • M Offline
      M Offline
      Mcjean
      wrote on sidst redigeret af
      #2412

      Kræver det ikke også en melding senest fredag før vi kan håbe på noget kursdrivende?

      1 Reply Last reply
      0
      • J Offline
        J Offline
        JKY_VH
        wrote on sidst redigeret af
        #2413

        Hvis man undlod at købe Genmab i oktober fordi den så for dyr ud, så https://www.nordnet.dk/mux/web/analys/nyheter/visaNyhet.html?itemid=371383013&sourcecode=ddk

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #2414

          Der kommer meddelser fra Genmab - om de kommer løbende eller før åbning mandag morgen er svært at sige.

          1 Reply Last reply
          0
          • M Offline
            M Offline
            Mcjean
            wrote on sidst redigeret af
            #2415

            Håber guldkornet er så stort at de må se sig nødsaget til at melde ud fredag:-) sagde JDW ikke noget med at ørerne ville gøre ondt med alle de gode nyheder?

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #2416

              Tror det gik på den immunmodulerende effekt - glæder mig til det hele, men kursmæssigt er det måske vigtigst med de korte briller at Dara-Rev-Dex kombien viser overbevisende CR

              1 Reply Last reply
              0
              • D Offline
                D Offline
                dohk
                wrote on sidst redigeret af
                #2417

                Link Preview Image
                FDA approves new Bristol-Myers treatment for multiple myeloma

                The U.S. Food and Drug Administration said on Monday it had approved a drug to be sold by Bristol-Myers Squibb Co as a treatment for a form of blood cancer. The FDA said it approved the treatment, Empliciti, to be used in multiple myeloma patients in combination with Celgene Corp's Revlimid and common anti-inflammatory drug dexamethasone. The National Cancer Institute estimates there will be 26,850 new cases of multiple myeloma and 11,240 related deaths in the United States in 2015.

                favicon

                Yahoo Finance (finance.yahoo.com)

                1 Reply Last reply
                0
                • D Offline
                  D Offline
                  dohk
                  wrote on sidst redigeret af
                  #2418

                  Så kom emplicit godkendelsen.

                  1 Reply Last reply
                  0
                  • J Offline
                    J Offline
                    Jedi
                    wrote on sidst redigeret af
                    #2419

                    PFS 19.4 mdr med Elo-Len-Dex (14.9 mdr med Len-Dex alene) - det er den PFS Dara-Len-Dex gerne skal slå i Pollux studiet. Kan vi få en indikation af PFS fra Dara-Len-Dex fase 2 kombi studiet på ASH?

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      Jedi
                      wrote on sidst redigeret af
                      #2420

                      Access to this page has been denied

                      px-captcha

                      favicon

                      (seekingalpha.com)

                      1 Reply Last reply
                      0
                      • M Offline
                        M Offline
                        Mcjean
                        wrote on sidst redigeret af
                        #2421

                        http://oasm.finanstilsynet.dk/dk/vismeddelelse.aspx?aid=5fb5cd59-0024-471a-b561-b3eff2b89715 31 aug. 59.322.130 stk - nu 209.133 stk's flere aktier. Nogen der kan

                        1 Reply Last reply
                        0
                        • M Offline
                          M Offline
                          Mcjean
                          wrote on sidst redigeret af
                          #2422

                          se udnyttelsesgraden og sige et eller andet begavet om det?

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #2423

                            Hvorfor er der to dara/len(rev)
                            /dex studier - Gen503 og Pollux?

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #2424

                              Har nu mere ondt af Marshall Wace 😉

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #2425

                                Gen503 var jo et fase 1/2 dose escalation study, dar var baggrunden for Pollux.

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #2426

                                  Jamen Gen503 er jo det
                                  der kommer på ASH nu

                                  1 Reply Last reply
                                  0
                                  • Legolas23L Offline
                                    Legolas23L Offline
                                    Legolas23
                                    wrote on sidst redigeret af
                                    #2427

                                    Kommer der nyt fra både Castor og Pollux ?

                                    1 Reply Last reply
                                    0
                                    • BudweisB Offline
                                      BudweisB Offline
                                      Budweis
                                      wrote on sidst redigeret af
                                      #2428

                                      Fra dagens Deutche analyse af pharma og biotek sektoren i EU - "In our view Actelion, Genmab and SOBI are the most likely takeout targets as they have strong recently approved potential blockbuster products and better shareholder structure"

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #2429

                                        🙂 Let it come

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #2430

                                          Tak Budweis. 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger